Given the central role of inflammation and vascular dysfunction in the development of preeclampsia, this study aimed to evaluate the relationship between the fibrinogen-to-albumin ratio (FAR) multiplied by 100 (FAR × 100) and risk of preeclampsia in this high-risk group. The gene discussed is ALB; the disease is preeclampsia.